Richard I Steinhart's Net Worth

$473 Thousand

Estimate Recalculated Apr 11, 2024 03:07PM EST

Who is Richard I Steinhart?

Richard I Steinhart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MANHATTAN PHARMACEUTICALS INC, BioXcel Therapeutics, Inc., Actinium Pharmaceuticals, Inc., MELA SCIENCES, INC. /NY, and ATOSSA THERAPEUTICS, INC..

SEC CIK

Richard I Steinhart's CIK is 0001293789

Past Insider Trading and Trends

2018 was Richard I Steinhart's most active year for acquiring shares with 9 total transactions. Richard I Steinhart's most active month to acquire stocks was the month of February. 2023 was Richard I Steinhart's most active year for disposing of shares, totalling 6 transactions. Richard I Steinhart's most active month to dispose stocks was the month of April. 2013 saw Richard I Steinhart paying a total of $337,092.00 for 235,754 shares, this is the most they've acquired in one year. In 2021 Richard I Steinhart cashed out on 7,500 shares for a total of $180,562.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MANHATTAN PHARMACEUTICALS INC (TGTX) Snapshot price: $15.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 25
Form 4
∞
5.63K
—
—
5.63K
Jan 30
Form 4
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
Sep 27
Form 3
—
0
—
—
0
No matching records found

BioXcel Therapeutics, Inc. (BTAI) Snapshot price: $3.765

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+55.57%
1.7K
$2.64
-$2,816.81
4.76K
Scheduled
Mar 14 - Apr 4
Form 4
+20.50%
521
—
—
3.06K
Dec 14
Form 4
+25.78%
521
—
—
2.54K
Sep 14
Form 4
+34.73%
521
—
—
2.02K
Jun 14
Form 4
—
0
$27.17
-$135,863.50
1.5K
May 14 - May 15
Form 4
—
0
$19.50
-$40,638.00
1.5K
Scheduled
Mar 14 - Mar 15
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Mar 14
Form 4
—
0
—
—
0
Mar 25
Form 4
—
0
$26.85
-$159,750.00
1.5K
Scheduled
Feb 1
Form 4
—
0
—
—
0
May 26
Form 4
+50.00%
500
$5.20
$2,599.95
1.5K
Dec 3
Form 4
+100.00%
500
$5.00
$2,500.00
1K
Nov 30
Form 4
∞
500
$5.00
$2,500.00
500
Nov 29
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found

Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $5.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 28
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Sep 1
Form 4
—
0
—
—
0
Aug 12
Form 4
—
0
—
—
0
Jul 12
Form 4
—
0
—
—
0
Jul 13
Form 4
+280.00%
7K
$0.50
$3,500.00
9.5K
Mar 6
Form 4
—
0
—
—
0
Mar 14
Form 4
∞
2.5K
$2.01
$5,025.00
2.5K
Apr 14 - Apr 15
Form 4
—
0
—
—
0
Feb 18
Form 4
—
0
—
—
0
Dec 16
Form 3
—
0
—
—
0
No matching records found

MELA SCIENCES, INC. /NY (SSKN) Snapshot price: $0.57

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Aug 5
Form 4
+300.00%
3K
$0.81
$2,427.00
4K
Jun 25
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Apr 25
Form 4
∞
1K
$6.32
$6,320.00
1K
Aug 12
Form 4
—
0
—
—
0
May 13
Form 3
—
0
—
—
0
No matching records found

ATOSSA THERAPEUTICS, INC. (ATOS) Snapshot price: $0.9423

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 12
Form 4
-100.00%
-22.73K
—
—
0
May 6
Form 4
∞
22.73K
—
—
22.73K
Mar 1
Form 3
—
0
—
—
0
No matching records found